SERINA THERAPEUTICS INC. (SER) Forecast, Price Target & Analyst Ratings

NYSEARCA:SER • US81751A1088

Current stock price

1.98 USD
-0.02 (-1%)
At close:
1.9008 USD
-0.08 (-4%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SERINA THERAPEUTICS INC. (SER).

Forecast Snapshot

Consensus Price Target

Price Target
$13.26
+ 569.70% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.43
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$13.26
Upside
+ 569.70%
From current price of $1.98 to mean target of $13.26, Based on 6 analyst forecasts
Low
$11.11
Median
$13.26
High
$15.75

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for SER. The average price target is 13.26 USD. This implies a price increase of 569.7% is expected in the next year compared to the current price of 1.98.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SER Current Analyst RatingSER Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

SER Historical Analyst RatingsSER Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
SER was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SER.
In the previous month the buy percentage consensus was at a similar level.
SER was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-14HC Wainwright & Co.Initiate Buy
2025-03-11Jones TradingInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.43
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
11.37%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

SER is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.43 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
SER revenue by date.SER revenue by date.
30K
-78.57%		142K
373.33%		56K
-60.56%		131.3K
134.46%
-100.00%		27.773M
EBITDA
YoY % growth
SER ebitda by date.SER ebitda by date.
-6.85M
13.40%		-9.829M
-43.49%		-16.854M
-71.47%		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
SER ebit by date.SER ebit by date.
-6.98M
13.18%		-9.96M
-42.69%		-17.048M
-71.16%		-23.351M
-36.97%		-30.458M
-30.43%		-34.066M
-11.85%		-42.567M
-24.95%		-49.497M
-16.28%		-56.574M
-14.30%		-57.814M
-2.19%		-72.805M
-25.93%		-59.117M
18.80%
Operating Margin
SER operating margin by date.SER operating margin by date.
-23,266.67%-7,014.08%-30,442.86%-17,784.62%N/AN/AN/AN/AN/AN/AN/A-212.86%
EPS
YoY % growth
SER eps by date.SER eps by date.
N/AN/AN/A-2.03-1.82
7.46%		-1.41
22.44%		-1.21
14.29%		-1.26
-4.17%		-1.14
9.60%		-1.16
-1.77%		-1.43
-23.48%		-1.08
24.65%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.43
11.37%		-0.39
40.32%		-0.40
21.77%		-0.40
-28.69%
Revenue
Q2Q % growth
-100.00%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-6.805M
-16.17%		-7.014M
-26.05%		-7.119M
-11.38%		-7.226M
-19.21%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SER Yearly Revenue VS EstimatesSER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2033 5M 10M 15M 20M 25M
SER Yearly EPS VS EstimatesSER Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
11.46%
EPS Next 5 Year
7.27%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SERINA THERAPEUTICS INC. / SER Forecast FAQ

Can you provide the average price target for SERINA THERAPEUTICS INC. stock?

6 analysts have analysed SER and the average price target is 13.26 USD. This implies a price increase of 569.7% is expected in the next year compared to the current price of 1.98.

When does SERINA THERAPEUTICS INC. (SER) report earnings?

SERINA THERAPEUTICS INC. (SER) will report earnings on 2026-05-11.

What are the consensus estimates for SER stock next earnings?

The consensus EPS estimate for the next earnings of SERINA THERAPEUTICS INC. (SER) is -0.43 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for SER stock?

The consensus rating for SERINA THERAPEUTICS INC. (SER) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.